Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.280
-0.020 (-1.54%)
At close: Aug 13, 2025, 4:00 PM
1.300
+0.020 (1.56%)
After-hours: Aug 13, 2025, 6:36 PM EDT
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,782,197
Market Cap
14.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CTXR News
- 1 day ago - Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 27 days ago - Citius Oncology Announces Closing of $9.0 Million Public Offering - PRNewsWire
- 4 weeks ago - Citius Oncology Announces Pricing of $9.0 Million Public Offering - PRNewsWire
- 4 weeks ago - Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora - PRNewsWire
- 5 weeks ago - Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 2 months ago - Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PRNewsWire
- 2 months ago - Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 2 months ago - Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules - PRNewsWire